臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yang j c h"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 271-295 / 428 (共18页)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2020-07-21T06:46:16Z	Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients	Yao Z.-H.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2020-07-21T06:46:16Z	Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations	Lin Y.-T.; Chen J.-S.; Liao W.-Y.; CHAO-CHI HO; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2020-07-21T06:46:15Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Chang Y.-L.; Su K.-Y.; Hsu C.-L.; Liu Y.-N.; Chen K.-Y.; Tsai T.-H.; Liao W.-Y.; CHAO-CHI HO; Yang C.-Y.
臺大學術典藏	2020-07-21T06:25:18Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Chang Y.-L.;Shih J.-Y.;Liu Y.-N.;Tsai M.-F.;Tzu-Hsiu Tsai;Yu C.-J.;Yang J.C.-H.;Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; TZU-HSIU TSAI; Yu C.-J.; Yang J.C.-H.; Yang P.-C.
臺大學術典藏	2020-07-21T06:25:18Z	Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy	Yang P.-C.; Shih J.-Y.; Yang J.C.H.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Jan I.-S.; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; Yang C.-Y.; TZU-HSIU TSAI
臺大學術典藏	2020-07-21T06:25:17Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Yang J.C.-H.; Thress K.S.; Huang D.D.-R.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tzu-Hsiu Tsai;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; TZU-HSIU TSAI; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.
臺大學術典藏	2020-07-21T06:25:17Z	Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion	Tzu-Hsiu Tsai;Wu S.-G.;Hsieh M.-S.;Yu C.-J.;Yang J.C.H.;Shih J.-Y.; TZU-HSIU TSAI; Wu S.-G.; Hsieh M.-S.; Yu C.-J.; Yang J.C.H.; Shih J.-Y.
臺大學術典藏	2020-07-21T06:25:17Z	IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer	Shih J.-Y.; Liu Y.-N.;Chang T.-H.;Tsai M.-F.;Wu S.-G.;Tzu-Hsiu Tsai;Chen H.-Y.;Yu S.-L.;Yang J.C.-H.;Shih J.-Y.; Liu Y.-N.; Chang T.-H.; Tsai M.-F.; Wu S.-G.; TZU-HSIU TSAI; Chen H.-Y.; Yu S.-L.; Yang J.C.-H.
臺大學術典藏	2020-07-21T06:25:15Z	Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors	Shih J.-Y.; Liao W.-Y.; Lee J.-H.;Chen H.-Y.;Hsu F.-M.;Chen J.-S.;Liao W.-Y.;Shih J.-Y.;Yu C.-J.;Chen K.-Y.;Tzu-Hsiu Tsai;Yang J.C.-H.; Lee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Yang J.C.-H.; Yu C.-J.; Chen K.-Y.; TZU-HSIU TSAI
臺大學術典藏	2020-07-21T06:09:14Z	Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy	Tsai T.-H.;Yang C.-Y.;Ho C.-C.;Wei-Yu Liao;Jan I.-S.;Chen K.-Y.;Wang J.-Y.;Ruan S.-Y.;Yu C.-J.;Yang J.C.H.;Yang P.-C.;Shih J.-Y.; Tsai T.-H.; Yang C.-Y.; Ho C.-C.; WEI-YU LIAO; Jan I.-S.; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; Yu C.-J.; Yang J.C.H.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2020-07-21T06:09:14Z	Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer	Wei-Yu Liao;Chen J.-H.;Wu M.;Shih J.-Y.;Chen K.-Y.;Ho C.-C.;Yang J.C.-H.;Yu C.-J.; WEI-YU LIAO; Chen J.-H.; Wu M.; Shih J.-Y.; Chen K.-Y.; Ho C.-C.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2020-07-21T06:09:13Z	Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer	Yang J.C.-H.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; WEI-YU LIAO; Yang P.-C.; Chen H.-Y.; Hsu W.-H.; Lin Y.-L.; Lee J.-H.; Lee J.-H.;Lin Y.-L.;Hsu W.-H.;Chen H.-Y.;Chang Y.-C.;Yu C.-J.;Shih J.-Y.;Lin C.-C.;Chen K.-Y.;Ho C.-C.;Wei-Yu Liao;Yang P.-C.;Yang J.C.-H.
臺大學術典藏	2020-07-21T06:09:10Z	Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis	Chen L.-Y.;Molina-Vila M.A.;Ruan S.-Y.;Su K.-Y.;Wei-Yu Liao;Yu K.-L.;Ho C.-C.;Shih J.-Y.;Yu C.-J.;Yang J.C.H.;Rosell R.;Yang P.-C.; Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; WEI-YU LIAO; Yu K.-L.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C.
臺大學術典藏	2020-07-21T06:09:09Z	Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib	Yu C.-J.; Yang J.C.H.; Yao Z.-H.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.H.;Yu C.-J.; Yao Z.-H.; WEI-YU LIAO; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.
臺大學術典藏	2020-07-21T06:09:07Z	Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery	Hsu F.-M.; Yang P.-C.; Yang W.-C.;Xiao F.;Shih J.-Y.;Ho C.-C.;Chen Y.-F.;Tseng H.-M.;Chen K.-Y.;Wei-Yu Liao;Yu C.-J.;Yang J.C.-H.;Kuo S.-H.;Cheng J.C.-H.;Yang P.-C.;Hsu F.-M.; Yang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; Chen K.-Y.; WEI-YU LIAO; Yu C.-J.; Yang J.C.-H.; Cheng J.C.-H.; Kuo S.-H.
臺大學術典藏	2020-07-21T06:09:06Z	Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients	Shih J.-Y.; Ho C.-C.; Wu T.-H.;Hsiue E.H.-C.;Lee J.-H.;Lin C.-C.;Wei-Yu Liao;Ho C.-C.;Shih J.-Y.;Yu C.-J.;Yang J.C.-H.; Wu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; WEI-YU LIAO; Yu C.-J.; Yang J.C.-H.
臺大學術典藏	2020-07-21T06:09:04Z	Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations	Yu C.-J.; Shih J.-Y.; Yang J.C.-H.; Lin Z.-Z.; Lee J.-H.; Chen K.-Y.; Yang C.-Y.; Hsu C.-L.; Ho C.-C.; WEI-YU LIAO; Chen J.-S.; Lin Y.-T.
臺大學術典藏	2020-07-21T06:09:03Z	Exon 16–Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M–Positive Non–Small Cell Lung Cancer	Thress K.; Yang J.C.-H.; Stetson D.; Markovets A.; WEI-YU LIAO; Liao B.-C.; Hsu C.-C.; Hsu C.-C.;Liao B.-C.;Wei-Yu Liao;Markovets A.;Stetson D.;Thress K.;Yang J.C.-H.
臺大學術典藏	2020-07-21T06:09:03Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Chen K.-Y.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO; Yang C.-Y.; Yang C.-Y.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yu C.-J.; Yang J.C.-H.; Shih J.-Y.; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liao B.-C.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.
臺大學術典藏	2020-07-21T05:40:29Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Lee J.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Ching-Yao Yang;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; CHING-YAO YANG; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.
臺大學術典藏	2020-07-20T05:28:00Z	Weaning outcome of solid cancer patients requiring mechanical ventilation in the intensive care unit	Hsiue E.H.-C.; PEI-LIN LEE; Chen Y.-H.; Wu T.-H.; Cheng C.-F.; Cheng K.-M.; Yang P.-C.; Chen H.-W.; Lin P.-Y.; Chiang D.-L.; Wu H.-D.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2020-06-30T08:09:56Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Kang-Yi Su;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; KANG-YI SU; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.
臺大學術典藏	2020-06-30T08:09:52Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Kang-Yi Su;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; KANG-YI SU; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2020-06-30T08:09:51Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Kang-Yi Su;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; KANG-YI SU; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2020-05-25T07:35:28Z	Optimal management of patients with non-small cell lung cancer and epidermal growth factor receptor mutations	Chia-Chi Lin; Yang J.C.-H.

显示项目 271-295 / 428 (共18页)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :2826576
	造访人次 : 31998837 在线人数 : 1060 教育部委托研究计画计画执行:国立台湾大学图书馆